Oracle CRM Integration up to 26.6 Open Integration improper authorization
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.0 | $5k-$25k | 0.79 |
Summary
A vulnerability classified as problematic was found in Oracle CRM Integration up to 26.6. This affects an unknown part of the component Open Integration. Executing a manipulation can lead to improper authorization. This vulnerability is tracked as CVE-2026-62593. The attack can be launched remotely. No exploit exists.
Details
A vulnerability was found in Oracle CRM Integration up to 26.6. It has been declared as problematic. This vulnerability affects an unknown function of the component Open Integration. The manipulation with an unknown input leads to a improper authorization vulnerability. The CWE definition for the vulnerability is CWE-285. The product does not perform or incorrectly performs an authorization check when an actor attempts to access a resource or perform an action. As an impact it is known to affect confidentiality. CVE summarizes:
Vulnerability in the Siebel CRM Integration product of Oracle Siebel CRM (component: Open Integration). Supported versions that are affected are 25.12-26.6. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Siebel CRM Integration. While the vulnerability is in Siebel CRM Integration, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Siebel CRM Integration accessible data. CVSS 3.1 Base Score 7.7 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:N/A:N).
The advisory is shared for download at oracle.com. This vulnerability was named CVE-2026-62593 since 07/14/2026. The exploitation appears to be easy. The attack can be initiated remotely. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $5k-$25k (estimation calculated on 08/19/2026). The MITRE ATT&CK project declares the attack technique as T1548.002.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Once again VulDB remains the best source for vulnerability data.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.0VulDB Meta Temp Score: 6.0
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 7.7
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Improper authorizationCWE: CWE-285 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
07/14/2026 CVE reserved08/19/2026 Advisory disclosed
08/19/2026 VulDB entry created
08/19/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-62593 (🔒)
GCVE (CVE): GCVE-0-2026-62593
GCVE (VulDB): GCVE-100-392812
Entry
Created: 08/19/2026 07:04Changes: 08/19/2026 07:04 (62)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.